We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Omnicell (OMCL) USD (CDI)

Sell:$32.20 Buy:$32.24 Change: $0.40 (1.25%)
Market closed |  Prices as at close on 22 May 2024 | Switch to live prices |
Change: $0.40 (1.25%)
Market closed |  Prices as at close on 22 May 2024 | Switch to live prices |
Change: $0.40 (1.25%)
Market closed |  Prices as at close on 22 May 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.

Contact details

United States
+1 (650) 2516100

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$1.41 billion
Shares in issue:
45.92 million
Health Care Equipment
United States
US dollar
NASDAQ Comb. Composite

Key personnel

  • Randall Lipps
    Chairman of the Board, President, Chief Executive Officer
  • Nchacha Etta
    Chief Financial Officer, Executive Vice President
  • Corey Manley
    Executive Vice President and Chief Legal and Administrative Officer
  • Joseph Spears
    Senior Vice President, Chief Accounting Officer, Corporate Controller
  • Brian Nutt
    Chief Accounting Officer, Vice President

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.